Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung
7680650410058
CH-65041
Injektionslösung
Associated product:
XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
1 / 3
google
Article details
- Package size
- 3 x 3
- Selling units
- 3
- Measure
- ml
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 NMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
100.0 U | Substance | WIIS |
|
(N/A)
|
3.6 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 143.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2014
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 65041
- Drug name
- Xultophy, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- A10AE56
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 12/09/2014
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.06.
- Domain
- Human medicine
Package details
- Description (FR)
- XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
- Description (DE)
- XULTOPHY 100E/ml 3.6 mg/ml 3 Fertpen 3 ml
- Market launch
- 12/09/2014
- Narcotic (BTM)
- No
Other package sizes (1)
None
None None
GTIN: None